The structural basis of PTEN regulation by multi-site phosphorylation.
Journal
Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
05
09
2020
accepted:
26
08
2021
entrez:
9
10
2021
pubmed:
10
10
2021
medline:
23
11
2021
Statut:
ppublish
Résumé
Phosphatase and tensin homolog (PTEN) is a phosphatidylinositol-3,4,5-triphosphate (PIP
Identifiants
pubmed: 34625746
doi: 10.1038/s41594-021-00668-5
pii: 10.1038/s41594-021-00668-5
pmc: PMC8549118
mid: NIHMS1747676
doi:
Substances chimiques
PTEN Phosphohydrolase
EC 3.1.3.67
PTEN protein, human
EC 3.1.3.67
Banques de données
Dryad
['10.5061/dryad.dfn2z34zh']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
858-868Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM136859
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM120855
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA221830
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008403
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA074305
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM078221
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA242461
Pays : United States
Organisme : NIGMS NIH HHS
ID : K99 GM130961
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB002026
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM080189
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
pubmed: 9593664
doi: 10.1074/jbc.273.22.13375
Worby, C. A. & Dixon, J. E. Pten. Annu. Rev. Biochem. 83, 641–669 (2014).
pubmed: 24905788
doi: 10.1146/annurev-biochem-082411-113907
Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
pubmed: 9072974
doi: 10.1126/science.275.5308.1943
Chalhoub, N. & Baker, S. J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4, 127–150 (2009).
pubmed: 18767981
doi: 10.1146/annurev.pathol.4.110807.092311
pmcid: 2710138
Manning, B. D. & Toker, A. AKT/PKB signaling: navigating the network. Cell 169, 381–405 (2017).
pubmed: 28431241
doi: 10.1016/j.cell.2017.04.001
pmcid: 5546324
Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway? Nat. Rev. Clin. Oncol. 15, 273–291 (2018).
pubmed: 29508857
doi: 10.1038/nrclinonc.2018.28
Kotelevets, L., Trifault, B., Chastre, E. & Schott, M. G. H. Posttranslation regulation and conformational plasticity of PTEN. Cold Spring Harb. Perspect. Med. 7, a036095 (2020).
doi: 10.1101/cshperspect.a036095
Campbell, R. B., Liu, F. & Ross, A. H. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 278, 33617–33620 (2003).
pubmed: 12857747
doi: 10.1074/jbc.C300296200
Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H. & Downes, C. P. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem. J. 379, 301–307 (2004).
pubmed: 14711368
doi: 10.1042/bj20031839
pmcid: 1224073
Iijima, M., Huang, Y. E., Luo, H. R., Vazquez, F. & Devreotes, P. N. Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J. Biol. Chem. 279, 16606–16613 (2004).
pubmed: 14764604
doi: 10.1074/jbc.M312098200
Lee, J. O. et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323–334 (1999).
pubmed: 10555148
doi: 10.1016/S0092-8674(00)81663-3
Vazquez, F., Ramaswamy, S., Nakamura, N. & Sellers, W. R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell Biol. 20, 5010–5018 (2000).
pubmed: 10866658
doi: 10.1128/MCB.20.14.5010-5018.2000
pmcid: 85951
Torres, J. & Pulido, R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993–998 (2001).
pubmed: 11035045
doi: 10.1074/jbc.M009134200
Henager, S. H. et al. Enzyme-catalyzed expressed protein ligation. Nat. Methods 13, 925–927 (2016).
pubmed: 27669326
doi: 10.1038/nmeth.4004
pmcid: 5088058
Bolduc, D. et al. Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. eLife 2, e00691 (2013).
pubmed: 23853711
doi: 10.7554/eLife.00691
pmcid: 3707082
Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S. & Mustelin, T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3β. J. Biol. Chem. 280, 35195–35202 (2005).
pubmed: 16107342
doi: 10.1074/jbc.M503045200
Dempsey, D. R. & Cole, P. A. Protein chemical approaches to understanding PTEN lipid phosphatase regulation. Methods Enzymol. 607, 405–422 (2018).
pubmed: 30149868
doi: 10.1016/bs.mie.2018.05.007
pmcid: 6231048
Chen, Z. et al. Molecular features of phosphatase and tensin homolog (PTEN) regulation by C-terminal phosphorylation. J. Biol. Chem. 291, 14160–14169 (2016).
pubmed: 27226612
doi: 10.1074/jbc.M116.728980
pmcid: 4933174
Masson, G. R., Perisic, O., Burke, J. E. & Williams, R. L. The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activity. Biochem. J. 473, 135–144 (2016).
pubmed: 26527737
doi: 10.1042/BJ20150931
Das, S., Dixon, J. E. & Cho, W. Membrane-binding and activation mechanism of PTEN. Proc. Natl Acad. Sci. USA 100, 7491–7496 (2003).
pubmed: 12808147
doi: 10.1073/pnas.0932835100
pmcid: 164614
Chen, Z. et al. Enzymatic analysis of PTEN ubiquitylation by WWP2 and NEDD4-1 E3 ligases. Biochemistry 55, 3658–3666 (2016).
pubmed: 27295432
doi: 10.1021/acs.biochem.6b00448
Nguyen, H. N. et al. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium. Oncogene 33, 5688–5696 (2014).
pubmed: 24292679
doi: 10.1038/onc.2013.507
Rahdar, M. et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc. Natl Acad. Sci. USA 106, 480–485 (2009).
pubmed: 19114656
doi: 10.1073/pnas.0811212106
Dempsey, D. R., Jiang, H., Kalin, J. H., Chen, Z. & Cole, P. A. Site-specific protein labeling with N-hydroxysuccinimide-esters and the analysis of ubiquitin ligase mechanisms. J. Am. Chem. Soc. 140, 9374–9378 (2018).
pubmed: 30016585
doi: 10.1021/jacs.8b05098
pmcid: 6093203
Nguyen, H. N. et al. Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities. Proc. Natl Acad. Sci. USA 111, E2684–E2693 (2014).
pubmed: 24979808
doi: 10.1073/pnas.1409433111
pmcid: 4084459
Muir, T. W., Sondhi, D. & Cole, P. A. Expressed protein ligation: a general method for protein engineering. Proc. Natl Acad. Sci. USA 95, 6705–6710 (1998).
pubmed: 9618476
doi: 10.1073/pnas.95.12.6705
pmcid: 22605
Henager, S. H., Henriquez, S., Dempsey, D. R. & Cole, P. A. Analysis of site-specific phosphorylation of PTEN by using enzyme-catalyzed expressed protein ligation. Chembiochem 21, 64–68 (2020).
pubmed: 31206229
doi: 10.1002/cbic.201900316
Murata, Y., Iwasaki, H., Sasaki, M., Inaba, K. & Okamura, Y. Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor. Nature 435, 1239–1243 (2005).
pubmed: 15902207
doi: 10.1038/nature03650
Iwasaki, H. et al. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate. Proc. Natl Acad. Sci. USA 105, 7970–7975 (2008).
pubmed: 18524949
doi: 10.1073/pnas.0803936105
pmcid: 2430346
Matsuda, M. et al. Crystal structure of the cytoplasmic phosphatase and tensin homolog (PTEN)-like region of Ciona intestinalis voltage-sensing phosphatase provides insight into substrate specificity and redox regulation of the phosphoinositide phosphatase activity. J. Biol. Chem. 286, 23368–23377 (2011).
pubmed: 21543329
doi: 10.1074/jbc.M110.214361
pmcid: 3123101
Liu, L. et al. A glutamate switch controls voltage-sensitive phosphatase function. Nat. Struct. Mol. Biol. 19, 633–641 (2012).
pubmed: 22562138
doi: 10.1038/nsmb.2289
pmcid: 3529583
Wei, Y., Stec, B., Redfield, A. G., Weerapana, E. & Roberts, M. F. Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation. J. Biol. Chem. 290, 1592–1606 (2015).
pubmed: 25429968
doi: 10.1074/jbc.M114.588590
Jang, H., Smith, I., Eng, C. & Nussinov, R. The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane. iScience 24, 102438 (2021).
pubmed: 34113810
doi: 10.1016/j.isci.2021.102438
pmcid: 8169795
Rayaprolu, V., Royal, P., Stengel, K., Sandoz, G. & Kohout, S. C. Dimerization of the voltage-sensing phosphatase controls its voltage-sensing and catalytic activity. J. Gen Physiol. 150, 683–696 (2018).
pubmed: 29695412
doi: 10.1085/jgp.201812064
pmcid: 5940254
Salzmann, M., Pervushin, K., Wider, G., Senn, H. & Wuthrich, K. TROSY in triple-resonance experiments: new perspectives for sequential NMR assignment of large proteins. Proc. Natl Acad. Sci. USA 95, 13585–13590 (1998).
pubmed: 9811843
doi: 10.1073/pnas.95.23.13585
pmcid: 24862
Coote, P. W. et al. Optimal control theory enables homonuclear decoupling without Bloch–Siegert shifts in NMR spectroscopy. Nat. Commun. 9, 3014 (2018).
pubmed: 30069002
doi: 10.1038/s41467-018-05400-4
pmcid: 6070575
Dubey, A., Kadumuri, R. V., Jaipuria, G., Vadrevu, R. & Atreya, H. S. Rapid NMR assignments of proteins by using optimized combinatorial selective unlabeling. Chembiochem 17, 334–340 (2016).
pubmed: 26662553
doi: 10.1002/cbic.201500513
Kleiger, G., Saha, A., Lewis, S., Kuhlman, B. & Deshaies, R. J. Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates. Cell 139, 957–968 (2009).
pubmed: 19945379
doi: 10.1016/j.cell.2009.10.030
pmcid: 2804849
Santiago-Frangos, A., Jeliazkov, J. R., Gray, J. J. & Woodson, S. A. Acidic C-terminal domains autoregulate the RNA chaperone Hfq. eLife 6, e27049 (2017).
pubmed: 28826489
doi: 10.7554/eLife.27049
pmcid: 5606850
de Vries, S. J., van Dijk, M. & Bonvin, A. M. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 5, 883–897 (2010).
pubmed: 20431534
doi: 10.1038/nprot.2010.32
van Zundert, G. C. P. et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720–725 (2016).
pubmed: 26410586
doi: 10.1016/j.jmb.2015.09.014
Chu, N. et al. The structural determinants of PH domain-mediated regulation of Akt revealed by segmental labeling. eLife 9, e59151 (2020).
pubmed: 32744507
doi: 10.7554/eLife.59151
pmcid: 7438110
Liu, D., Xu, R. & Cowburn, D. Segmental isotopic labeling of proteins for nuclear magnetic resonance. Methods Enzymol. 462, 151–175 (2009).
pubmed: 19632474
doi: 10.1016/S0076-6879(09)62008-5
Rabenstein, D. L. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 19, 312–331 (2002).
pubmed: 12137280
doi: 10.1039/b100916h
Johnston, S. B. & Raines, R. T. Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L. PLoS ONE 10, e0116898 (2015).
pubmed: 25607987
doi: 10.1371/journal.pone.0116898
pmcid: 4301912
Gil, A. et al. A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity. PLoS ONE 10, e0119287 (2015).
pubmed: 25875300
doi: 10.1371/journal.pone.0119287
pmcid: 4398541
Mighell, T. L., Evans-Dutson, S. & O’Roak, B. J. A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships. Am. J. Hum. Genet. 102, 943–955 (2018).
pubmed: 29706350
doi: 10.1016/j.ajhg.2018.03.018
pmcid: 5986715
Padua, R. A. P. et al. Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2. Nat. Commun. 9, 4507 (2018).
pubmed: 30375376
doi: 10.1038/s41467-018-06814-w
pmcid: 6207724
Whittier, S. K. & Loria, J. P.
pubmed: 24026965
doi: 10.1007/s12104-013-9524-0
Choy, M. S. et al. Conformational rigidity and protein dynamics at distinct timescales regulate PTP1B activity and allostery. Mol. Cell 65, 644–658 (2017).
pubmed: 28212750
doi: 10.1016/j.molcel.2017.01.014
pmcid: 5325675
McConnachie, G., Pass, I., Walker, S. M. & Downes, C. P. Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. Biochem. J. 371, 947–955 (2003).
pubmed: 12534371
doi: 10.1042/bj20021848
pmcid: 1223325
Maccario, H., Perera, N. M., Davidson, L., Downes, C. P. & Leslie, N. R. PTEN is destablized by phosphorylation on Thr 366. Biochem. J. 405, 439–444 (2007).
pubmed: 17444818
doi: 10.1042/BJ20061837
pmcid: 2267318
Miller, M. S. et al. Getting the most out of your crystals: data collection at the new high-flux, microfocus MX beamlines at NSLS-II. Molecules 24, 496 (2019).
doi: 10.3390/molecules24030496
pmcid: 6384729
Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
pubmed: 20124692
doi: 10.1107/S0907444909047337
pmcid: 2815665
Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013).
pubmed: 23793146
doi: 10.1107/S0907444913000061
pmcid: 3689523
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240–255 (1997).
pubmed: 15299926
doi: 10.1107/S0907444996012255
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002
doi: 10.1107/S0907444910007493
pmcid: 2852313
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
pubmed: 17681537
doi: 10.1016/j.jmb.2007.05.022
Nikolovska-Coleska, Z. et al. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Anal. Biochem. 332, 261–273 (2004).
pubmed: 15325294
doi: 10.1016/j.ab.2004.05.055
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
pubmed: 8520220
doi: 10.1007/BF00197809
Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687–696 (2005).
pubmed: 15815974
doi: 10.1002/prot.20449
Hyberts, S. G., Milbradt, A. G., Wagner, A. B., Arthanari, H. & Wagner, G. Application of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled with multidimensional Poisson gap scheduling. J. Biomol. NMR 52, 315–327 (2012).
pubmed: 22331404
doi: 10.1007/s10858-012-9611-z
pmcid: 3321367
Schanda, P. & Brutscher, B. Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. J. Am. Chem. Soc. 127, 8014–8015 (2005).
pubmed: 15926816
doi: 10.1021/ja051306e
Schumann, F. H. et al. Combined chemical shift changes and amino acid specific chemical shift mapping of protein-protein interactions. J. Biomol. NMR 39, 275–289 (2007).
pubmed: 17955183
doi: 10.1007/s10858-007-9197-z
Khatib, F. et al. Algorithm discovery by protein folding game players. Proc. Natl Acad. Sci. USA 108, 18949–18953 (2011).
pubmed: 22065763
doi: 10.1073/pnas.1115898108
pmcid: 3223433
Marty, M. T. et al. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal. Chem. 87, 4370–4376 (2015).
pubmed: 25799115
doi: 10.1021/acs.analchem.5b00140
pmcid: 4594776